Literature DB >> 28898591

Emerging Opportunities and Challenges of Biosimilars in Oncology Practice.

Gary H Lyman1.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 28898591     DOI: 10.1200/JOP.2017.026831

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  2 in total

1.  Early Adoption of Biosimilar Growth Factors in Supportive Cancer Care.

Authors:  Xiaoxue Chen; Abiy Agiro; John Barron; David Debono; Michael Fisch
Journal:  JAMA Oncol       Date:  2018-12-01       Impact factor: 31.777

Review 2.  Current and future roles of biosimilars in oncology practice.

Authors:  Sofia Konstantinidou; Angeliki Papaspiliou; Eleni Kokkotou
Journal:  Oncol Lett       Date:  2019-11-15       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.